98% Breviscapine Erigeron Breviscapus Extract

• Customization: Available
• Certification: ISO, HACCP, Kosher
• Assay Method: HPLC, UV, Tlc
• Application Form: Tablet, Capsule
• Application: Food, Health Care Products, Medicine
• State: Powder
• Extract Source: Whole Plant
• Transport Package: Fiber Paper Drum
• Specification: 5%-98% Breviscapine
• Trademark: New Mstar
• Origin: China
• HS Code: 2938909090
• Production Capacity: 20 Tons/Month

Product Description

Breviscapine can expand cerebral blood vessels, reduce cerebral vascular resistance, increase cerebral blood flow, improve microcirculation, and combat platelet aggregation. Therefore, it can be used for the treatment of ischemic cerebrovascular diseases, such as cerebral thrombosis, cerebral embolism, cerebral hemorrhage and other sequelae paralysis patients, with better curative effect.

Applications:
1. Applied in the pharmaceutical field do medicine raw material;
2. Applied in the health product field;
3. Applied in the function food field.